Free Submission Public Relations &
Deutsch English


"BioMarin Pharmaceutical Inc. - SWOT, Strategy and Corporate Finance Report" is now available at Fast Market Research

Print article Print article
2014-01-25 00:06:23 - New Business research report from MarketLine is now available from Fast Market Research

BioMarin Pharmaceutical Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

This Report Features:

* Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
* An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and

key ratios for BioMarin Pharmaceutical Inc.
* Intelligence on BioMarin Pharmaceutical Inc.nv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- ..

Report Highlights:

BioMarin Pharmaceutical (BioMarin or 'the company'), a commercial-stage biopharmaceutical company, develops and commercializes biopharmaceuticals for the treatment of serious diseases and medical conditions. The company operates in the US, Europe and Latin America. It is headquartered in Novato, California, and employed 1,002 people as of January 27, 2012. The company recorded revenues of $441.4 million during the financial year ended December 2011 (FY2011), an increase of 17.3% over FY2010. The operating loss of the company was $33.9 million in FY2011, as compared with an operating profit of $0.5 million during FY2010. The net loss was $53.8 million in FY2011, as compared with a net profit of $205.8 million in FY2010.

Reasons to Get this Report:

* Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on BioMarin Pharmaceutical Inc.'s business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
-BioMarin Pharmaceutical Inc.: Company Overview
-BioMarin Pharmaceutical Inc.: Overview and Key Facts
--BioMarin Pharmaceutical Inc.: Overview
--BioMarin Pharmaceutical Inc.: Key Facts
-BioMarin Pharmaceutical Inc.: Key Employees
-BioMarin Pharmaceutical Inc.: Key Employee Biographies
-BioMarin Pharmaceutical Inc.: Major Products and Services
-BioMarin Pharmaceutical Inc.: Company History
-BioMarin Pharmaceutical Inc.: Management Statement
-BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
-BioMarin Pharmaceutical Inc.: Key Competitors
BioMarin Pharmaceutical Inc.: Company Analysis
-BioMarin Pharmaceutical Inc.: Business Description
-BioMarin Pharmaceutical Inc.: SWOT Analysis
--BioMarin Pharmaceutical Inc.: SWOT Overview
--BioMarin Pharmaceutical Inc.: Strengths
--BioMarin Pharmaceutical Inc.: Weaknesses
--BioMarin Pharmaceutical Inc.: Opportunities
--BioMarin Pharmaceutical Inc.: Threats
-BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
-BioMarin Pharmaceutical Inc.: Financial Deals Overview
-BioMarin Pharmaceutical Inc.: Targets and Partners
-BioMarin Pharmaceutical Inc.: Top Deals 2010 - 2014YTD*
-BioMarin Pharmaceutical Inc.: Advisors
--BioMarin Pharmaceutical Inc.: Top Legal Advisors
--BioMarin Pharmaceutical Inc.: Top Financial Advisors
-BioMarin Pharmaceutical Inc.: Mergers and Acquisitions
-BioMarin Pharmaceutical Inc.: Corporate Venturing
-BioMarin Pharmaceutical Inc.: Capital Raising
-BioMarin Pharmaceutical Inc.: Partnership
BioMarin Pharmaceutical Inc.: Recent Developments
-BioMarin Pharmaceutical Inc.: News and Events Summary
-BioMarin Pharmaceutical Inc.: Contracts
-BioMarin Pharmaceutical Inc.: Financial Deals
-BioMarin Pharmaceutical Inc.: Financial Performance
-BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
-BioMarin Pharmaceutical Inc.: Research & Development
-Contact Us
-About Datamonitor

List of Tables

Table 1: BioMarin Pharmaceutical Inc.: Key Facts
Table 2: BioMarin Pharmaceutical Inc.: Key Employees
Table 4: BioMarin Pharmaceutical Inc.: Key Competitors
Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*)
Table 7: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2010 - YTD*2014)
Table 8: BioMarin Pharmaceutical Inc.: Targets and Partners
Table 9: BioMarin Pharmaceutical Inc.: Top Deals 2010 - 2014YTD*
Table 10: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 11: BioMarin Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 12: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2010 - YTD*2014)
Table 13: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2010 - YTD*2014)
Table 14: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2010 - YTD*2014)
Table 15: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2010 - YTD*2014)
Table 16: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2010 - YTD*2014)
Table 17: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2010 - YTD*2014)

Full Table of Contents is available at:

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact